The National Institutes of Health (NIH) funded Schepens Eye Research Institute of Mass. Eye and Ear’s P30 core grant competitive renewal (PI: Pablo Argüeso, PhD) at $3,940,010 over five years. This critical funding supports four shared core resources at 20 Staniford Street: Animal Resource, Flow Cytometry, Laboratory Computer Applications, and Morphology.
Joseph Arboleda-Velasquez, MD, PhD, received a grant from the National Institute of Neurological Disorders and Stroke and National Institute of Aging/National Institutes of Health in the amount of $1,016,301 over five years for his project, "Exploring the Role of Aging in Cerebral Ischemic Small Vessel Disease Using Notch3 Mutant Mice."
Mass. Eye and Ear researchers describe the role of endomucin, a molecule that – under healthy circumstances – resists the adhesion of white blood cells as they move through the circulatory system. These findings suggest that promoting the expression of endomucin (displayed in red in image) may prevent the collection of white blood cells that causes tissues to become inflamed.